Invention Grant
- Patent Title: Pharmaceutical composition
-
Application No.: US16631604Application Date: 2018-07-17
-
Publication No.: US11612563B2Publication Date: 2023-03-28
- Inventor: Christophe Roberge , Anthony Rech , Jean-Manuel Cros , Myriam Abbassi , Adolfo López-Noriega , Lea Pebrel , Audrey Petit , Juliette Serindoux
- Applicant: MedinCell , Christophe Roberge , Anthony Rech , Jean-Manuel Cros
- Applicant Address: FR Jacou; FR Jacou; FR Jacou; FR Jacou
- Assignee: MedinCell,Christophe Roberge,Anthony Rech,Jean-Manuel Cros
- Current Assignee: MedinCell,Christophe Roberge,Anthony Rech,Jean-Manuel Cros
- Current Assignee Address: FR Jacou; FR Jacou; FR Jacou; FR Jacou
- Agency: Birch, Stewart, Kolasch & Birch, LLP
- International Application: PCT/EP2018/069440 WO 20180717
- International Announcement: WO2019/016234 WO 20190124
- Main IPC: A61K9/00
- IPC: A61K9/00 ; A61K31/445 ; A61K31/519 ; A61K31/5415 ; A61K31/7048 ; A61K38/12 ; A61K47/34 ; C08G63/664 ; A61K31/167 ; A61K9/20

Abstract:
The present invention provides a biodegradable drug delivery composition comprising a mixture of at least two block copolymers taken among triblock and diblock copolymers comprising: (a) a biodegradable triblock copolymer having the formula: Av-Bw-Ax wherein A is a polyester and B is polyethylene glycol and v and x are from 1 to 3,000 and w is from 3 to 300 and v=x or v≠x; (b) a biodegradable diblock copolymer having the formula: Cy-Az wherein A is a polyester and C is an end-capped polyethylene glycol and y and z are the number of repeat units with y=2 to 250 and z=1 to 3,000; wherein the weight ratio between (a) and (b) is 1:19 to 5:1; and for at least one of the copolymers according to (a) or (b) A is poly(ε-caprolactone-co-lactide); and (c) at least one pharmaceutically active ingredient.
Public/Granted literature
- US20200171157A1 PHARMACEUTICAL COMPOSITION Public/Granted day:2020-06-04
Information query